Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Approval of a novel antibody-drug conjugate ushers in new second-line option.
Anti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.
Advances, challenges, and promising innovations emerge.
What many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
The oral medication activates an “anti-hunger” molecule which may prevent people from overeating.
Pharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Erenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Vanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.
My own experience has illustrated how embracing change can lead to growth.
As the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.
Achieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Key trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.
Currently, standard first-line chemotherapy with or without immunotherapy for patients with non-small-cell lung cancer (NSCLC) with HER2 mutations has limited efficacy.
Aducanumab-avwa is a monoclonal antibody that is the first treatment of its class designed to target the amyloid β protein, a biomarker of Alzheimer disease and other dementias.
Pharmacies can reach patients who are not receiving vaccines from a pharmacy but are willing to receive them.
Prevention methods, including smoking cessation and public education, remain critical in combating the United States’ third most common cancer type.
Experts in the management of SARS-CoV-2 educate on CDC and FDA recommendations for approaching administration of booster vaccines, including those for special patient populations.
One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.
A lack of access, awareness, and trust have led to a lack of affordability, effectiveness, and inclusivity.
Alexandra S. Wolff, PharmD, BCOP, comments on her experience with CPX-351 in clinical practice and the potential to combine CPX-351 with targeted agents for AML.
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
Answering questions, monitoring, medication therapy, lifestyle modifications help prevent type 2 diabetes.
Pharmacy Technician Day celebrates the myriad contributions of the unsung heroes of health care.
In recent years, telestroke services have transformed stroke care delivery, especially in rural or underserved areas.
PBMs can implement a clinically rigorous approach to specialty pharmacy management that ensures members have appropriate access while helping payers control their pharmacy spend.
Tips to help community-based pharmacists use the data at their fingertips to better market and provide the enhanced pharmacy services that drive practice transformation.
The oral therapy is available through a REMS program.